This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
In the context of increased demand within the daily growth hormone market, selected Genotropin Stock Keeping Units (SKUs) may experience a pressure upon supply. Please find up to date stock information below for each SKU:
| Device | SKU | Stock update | Out-of-stock expected / since |
Expected month of resupply |
|---|---|---|---|---|
| GoQuick | 12mg | Full supply | N/A | N/A |
| 5.3mg | Full supply | N/A | N/A | |
| Pen | 12mg | Full supply (cartridge) Full supply (pen device) |
N/A N/A |
N/A N/A |
| 5.3mg |
Full supply (cartridge) Full supply (pen device) |
N/A N/A |
N/A N/A |
|
| MiniQuick | 0.2mg | Out of stock | December 2024 | February 2025 |
| 0.4mg | Full supply | N/A | N/A | |
| 0.6mg | Full supply | N/A | N/A | |
| 0.8mg | Full supply | N/A | N/A | |
| 1.0mg | Full supply | N/A | N/A | |
| 1.2mg | Full supply | N/A | N/A | |
| 1.4mg | Full supply | N/A | N/A | |
| 1.6mg | Full supply | N/A | N/A | |
| 1.8mg | Full supply | N/A | N/A | |
| 2.0mg | Full supply | N/A | N/A |
Have you considered switching your eligible paediatric GHD Genotropin patients to once-weekly Ngenla?
Prescribing information for Ngenla®▼ (somatrogon) can be found here.
We apologise for any inconvenience this causes. Should you have any questions please reach out to your local Pfizer representative.
*Ngenla is indicated for the treatment of children and adolescents from 3 years of age with growth disturbance due to insufficient secretion of growth hormone.1
At Pfizer UK we have sufficient stock of our once-weekly growth hormone Ngenla to help minimise the Genotropin stock disruptions.
References:
1. NGENLA Summary of Product Characteristics for Great Britain: https://www.medicines.org.uk/emc/search?q=ngenla & Northern Ireland: https://www.emcmedicines.com/en-gb/northernireland/medicine?id=4319e9d0-5396-4363-8dcb-bc72051b39da&type=smpc
Continuous patient support to assist with troubleshooting and management of prescription changes without taking clinic time off an NHS nurse.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024